The document provides an in-depth 72-page report on the pharmaceutical market in Canada. It includes five-year projections of economic, demographic and pharmaceutical market indicators. It summarizes that the Canadian pharmaceutical market is projected to grow steadily through 2016 due to an aging population and commitment to healthcare, though government spending constraints could impact growth. It also notes that Canada has a strong domestic generic industry and pharmaceutical exports exceed $6 billion annually, driven partly by parallel trade with the US.